Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is a key regulator of mitochondrial biogenesis and respiration [27] that plays a critical role in the control of metabolism and energy homeostasis [28-30].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [30]
In the citing paper
“hepatic gluconeogenesis was suppressed, as witnessed by decreased expression of the FoxO1-regulated genes phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-phosphatase (G6P) [72].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [72]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“In contrast, insulin suppresses hepatic gluconeogenesi”
The Forkhead Transcription Factor Foxo1 Regulates Adipocyte Differentiation
Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., Arden, K. C., & Accili, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00401-x · Cited by 727
Self-citationPhosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Self-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Self-citation
Cited by
Items 901–1,000 of 1,000
Lerat, H., Imache, M. R., Polyte, J., Gaudin, A., Mercey-Ressejac, M., Donati, F., Baudesson, C., Higgs, M. R., Picard, A., Magnan, C., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.785030 · Cited by 23
HMGA1 is a novel transcriptional regulator of the FoxO1 gene
Arcidiacono, B., CHIEFARI, E. D., Messineo, S., Bilotta, F. L., Pastore, I., Corigliano, D. M., FOTI, D. P., & Brunetti, A. (2017) · Endocrine · doi:10.1007/s12020-017-1445-8 · Cited by 25
Kakazu, E., Mino, M., & Kanto, T. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2025.0048 · Cited by 28
Xu, T., Alharthi, A. S., Batistel, F., Helmbrecht, A., Parys, C., Trevisi, E., Shen, X., & Loor, J. J. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-14378 · Cited by 25
“The PI3K-AKT pathway can activate glycolysis and inhibit gluconeogenesis, and the inhibition of gluconeogenesis by AKT occurs by inhibiting FOXO1 through phosphorylation (Puigserver et al., 2003).”
BackgroundPolarization of Macrophages in Insects: Opening Gates for Immuno-Metabolic Research
Bajgar, A., Krejčová, G., & Doležal, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.629238 · Cited by 23
“FOXO increases the expression of genes involved in lipogenesis and glycogenolysis, as well as the production and release of lipoproteins (Puigserver et al., 2003).”
BackgroundDuan, X., Zhang, X., Chen, J., Xiao, M., Zhao, W., Liu, S., & Sui, G. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c01384 · Cited by 22
Wang, G., Zhang, J., Wu, S., Qin, S., Zheng, Y., Xia, C., Geng, H., Yao, J., & Deng, L. (2022) · Animal nutrition · doi:10.1016/j.aninu.2022.07.010 · Cited by 25
“According to previous research (Puigserver et al., 2003; Yoon et al., 2001), the transcription factor PGC-1a could bind to the promoters of FBP and PCK and initiate the expression of these two genes.”
MethodDu, H., Li, J., Wei, X., Yang, D., Zhang, B., Fan, X., Zhao, M., Zhu, R., Zhang, Z., Zhang, Y., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108445 · Cited by 26
Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis
Xu, T., Zhang, X., Zhao, W., Shi, J., Wan, S., Zhang, Y., Hao, Y., Sun, M., He, J., Jiang, L., et al. (2024) · Blood · doi:10.1182/blood.2024024293 · Cited by 23
Kim, O., Nam, D., Jun, W., & Lee, J. (2015) · Food & Nutrition Research · doi:10.3402/fnr.v59.29165 · Cited by 22
Kapadia, B. B., Viswakarma, N., Parsa, K. V. L., Kain, V., Behera, S., Suraj, S. K., Babu, P. P., Kar, A., Panda, S., Zhu, Y.-J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083787 · Cited by 24
“Numerous hepatic nuclear receptors including PPAR, TRβ1, HNF4α, FOXO1 and co-activators like PGC1α, CBP/Ep300, PRIP/NCoA6 and SRC1/2 are bound to PEPCK promoter either directly or indirectly and are essential for gluconeogenic response [20,47-51].”
BackgroundThe Hepatitis C Virus Modulates Insulin Signaling Pathway In Vitro Promoting Insulin Resistance
Campo, J. A. D., García-Valdecasas, M., Rojas, L., Rojas, Á., & Romero‐Gómez, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047904 · Cited by 23
Qadri, I., Choudhury, M., Rahman, S. M., Knotts, T. A., Janssen, R. C., Schaack, J. B., Iwahashi, M., Puljak, L., Simon, F. R., Kilic, G., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384743 · Cited by 26
“HCV induced an increase in activation of the major gluconeogenic transcription factors pCREB (Ser-133), C/EBP , FOXO1, and PGC-1 .”
BackgroundInfluentialSajan, M. P., Ivey, R. A., & Farese, R. V. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.011 · Cited by 23
Fine-tuned regulation of the PGC-1α gene transcription by different intracellular signaling pathways
Hong, T., Ning, J., Yang, X., Liu, H.-Y., Han, J., Liu, Z., & Cao, W. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00225.2010 · Cited by 23
“In the liver, PGC-1 stimulates de novo synthesis of glucose via gluconeogenesis to provide a fuel source for cells (neurons and red blood cells) that can only use glucose as their fuel source (32).”
BackgroundMetabolic Pathway Inhibition in Liver Cancer
Zarrinpar, A. (2017) · SLAS TECHNOLOGY · doi:10.1177/2472630317698683 · Cited by 23
Kasangana, P. B., Nachar, A., Eid, H. M., Stevanovic, T., & Haddad, P. S. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.09.017 · Cited by 25
Yano, H., Sakai, M., Matsukawa, T., Yagi, T., Naganuma, T., Mitsushima, M., Iida, S., Inaba, Y., Inoue, H., Unoki‐Kubota, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32575-z · Cited by 23
The FOX transcription factors regulate vascular pathology diabetes and Tregs
Yang, X. F., Fang, P., Meng, S., Jan, M., Xiong, X., Yin, Y., & Wang, H. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s35 · Cited by 24
Qin, W., Pan, J., Wu, Y., Bauman, W. A., & Cardozo, C. P. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.025 · Cited by 23
Li, L., Li, T., Zhang, Y., Pan, Z., Wu, B., Huang, X. H., Zhang, Y., Mei, Y., Ge, L., Shen, G., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.88 · Cited by 24
Miyagi, S., Takamura, T., Nguyen, T. T. T., Tsujiguchi, H., Hara, A., Nakamura, H., Suzuki, K., Tajima, A., Kannon, T., Toyama, T., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13402 · Cited by 22
Jiang, Y., Zhu, H., Chen, Z., Yu, Y., Guo, X., Chen, Y., Yang, M., Chen, B.-W., Sagnelli, M., Xu, D. Q., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.844707 · Cited by 28
Ma, D., Shuler, J. M., Raider, K. D., Rogers, R. S., Wheatley, J. L., Geiger, P. C., & Stanford, J. A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.053 · Cited by 21
“Its expression is downregulated in skeletal muscles of insulin resistant and T2D subjects (Canto and Auwerx, 2009), but upregulated in liver tissue from diabetic mice (Puigserver et al., 2003, Koo et al., 2004).”
BackgroundInsulin resistance and adipogenesis: Role of transcription and secreted factors
Penkov, D., Egorov, A. D., Мозговая, М. Н., & Va, T. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913010021 · Cited by 25
Global Analyses of Selective Insulin Resistance in Hepatocytes Caused by Palmitate Lipotoxicity
Li, Z., Lai, Z. W., Christiano, R., Gazos‐Lopes, F., Walther, T. C., & Farese, R. V. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000560 · Cited by 24
Jensen, K. A., Luu, T. C., & Chan, W. K. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600438 · Cited by 22
Analysis of FOXO1A as a candidate gene for type 2 diabetes
Karim, M. A., Craig, R. L., Wang, X., Hale, T. C., & Elbein, S. C. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.01.003 · Cited by 23
Gaudy, A. M., Clementi, A. H., Campbell, J. S., Smrcka, A. V., & Mooney, R. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159111 · Cited by 24
The role of protein translocation in the regulation of glycogen metabolism
Jurczak, M. J., Danos, A. M., Rehrmann, V. R., & Brady, M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21634 · Cited by 21
“…(C/EBP-a), the cAMP response element-binding protein (CREB), hepatocyte nuclear factor 4a (HNF4a), as well as the forkhead transcription factor, FOXO1 [Wang et al., 1995; Nakae et al., 2001; Boustead et al., 2003; Puigserver et al., 2003; Gautier-Stein et al., 2005; Schilling et al., 2006].”
BackgroundChahal, J., Chen, C., Rane, M. J., Moore, J. P., Barati, M. T., Song, Y., & Villafuerte, B. C. (2008) · Endocrinology · doi:10.1210/en.2007-1693 · Cited by 22
Insulin resistance in an energy-centered perspective
Wang, P., & Mariman, E. C. M. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.008 · Cited by 23
“Activated FOXO proteins can counteract the signals of insulin as for instance by stimulating gluconeogenesis [29,30].”
Zhang, Y., Gao, J., & Luo, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109053 · Cited by 22
Goncalves, J. F., Yu, W. C., Guo, X., Rha, K., LeBoeuf, B., Zhang, L., Estler, K., & Garcia, L. R. (2020) · iScience · doi:10.1016/j.isci.2020.100990 · Cited by 23
“PEPCK is also essential for mammals and C. elegans larvae to survive short and long periods iScience 23, 100990, April 24, 2020 7 8 iScience 23, 100990, April 24, 2020 of fasting (Hibshman et al., 2017; Puigserver et al., 2003; Rothman et al., 1991).”
BackgroundWang, Y., Fan, M., Qian, H., Ying, H., Li, Y., & Wang, L. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2183382 · Cited by 20
“In the liver, FoxO1-peroxisome proliferator-activated receptor-γ co-activator 1α (PGC-1α) interaction is crucial for insulin-regulated hepatic gluconeogenesis, which offers therapeutic benefits for glycaemic control (Langlet et al. 2017; Puigserver et al. 2003).”
Wu, J., Zhang, L., Liu, D., Xia, J., Yang, Y., Tang, F., Chen, L., Ao, H., & Peng, C. Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116955 · Cited by 22
Atageldiyeva, K. K., Fujita, Y., Yanagimachi, T., Mizumoto, K., Takeda, Y., Honjo, J., Takiyama, Y., Abiko, A., Makino, Y., & Haneda, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157672 · Cited by 21
Sun, J. H., Xiao, P.-Z., Chang, Z.-G., Ji, H., Du, Z., & Chen, L. (2016) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2016.11.011 · Cited by 21
Antifibrotic role of PGC-1α-siRNA against TGF-β1-induced renal interstitial fibrosis
Wang, J., Chen, C.-W., Tsai, M.-R., Liu, S., Hung, T.-J., Yu-Ju-Hung, Chang, W., Shi, M., Hsieh, P., & Yang, Y. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.06.016 · Cited by 23
Barooti, A., Kamran, M., Kharazmi, F., Eftakhar, E., Malekzadeh, K., Talebi, A., & Soltani, N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.164 · Cited by 20
Dapagliflozin attenuates renal gluconeogenic enzyme expression in obese rats
Swe, M. T., Thongnak, L., Jaikumkao, K., Pongchaidecha, A., Chatsudthipong, V., & Lungkaphin, A. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0480 · Cited by 21
Gaspar, R. C., Muñoz, V. R., Nakandakari, S. C. B. R., Vieira, R. F. L., da Conceição, L. R., de Oliveira, F., Crisol, B., da Silva, A. S. R., Cintra, D. E., de Moura, L. P., et al. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111021 · Cited by 20
Pérez-García, A., Hurtado-Carneiro, V., Herrero-de-Dios, C. M., Dongil, P., García‐Mauriño, J. E., Sánchez, M. D., Sanz, C., & Álvarez, E. (2021) · Nutrients · doi:10.3390/nu13082552 · Cited by 20
Nachar, A., Saleem, A., Arnason, J. T., & Haddad, P. S. (2015) · Phytochemistry · doi:10.1016/j.phytochem.2015.07.001 · Cited by 23
Overexpression of FOXO1 in skeletal muscle does not alter longevity in mice
Chiba, T., Kamei, Y., Shimizu, T., Shirasawa, T., Katsumata, A., Shiraishi, L., Sugita, S., Ogawa, Y., Miura, S., & Ezaki, O. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.04.004 · Cited by 23
“…the constitutively active mutant of FOXO1, increased the transcriptional activity with coexpression of peroxisome proliferator-activated receptor-g coactivator-1a (Puigserver et al., 2003), suggesting that wild-type FOXO1 acts like the active mutant of FOXO1 in the absence of insulin in the liver.”
Stahel, P., Kim, J. J., Cieslar, S. R. L., Warrington, J., Xiao, C., & Cant, J. P. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.12.012 · Cited by 25
“Akt-mediated phosphorylation of PGC-1α and FOXO1 leads to their exclusion from the nucleus, thereby decreasing gluconeogenic gene expression [31,32].”
BackgroundPhysiological and pathophysiological actions of insulin in the liver
Kubota, N., Kubota, T., & Kadowaki, T. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0192 · Cited by 19
“FoxO1 is localized in the nucleus, where it directly binds to the promoters of gluconeogenic genes, such as those encoding glucose 6-phosphatase ( G6Pase ) and phos‐ phoenol pyruvate carboxykinase ( PEPCK ), activating glucose production [44, 45].”
Hepatic Glucocorticoid Receptor Action and Glucose Homeostasis
Chang, M., & Wang, J.-C. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf030 · Cited by 22
Ji, L., Wu, S., Fu, D., Fang, S., Xie, G., Fan, Y., & Bao, J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114815 · Cited by 20
Wang, G., Xu, J., Ma, H., Mu, Y., Xu, W., Yan, N., Liu, W., Zheng, D., Huang, X., & Li, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106569 · Cited by 20
Atypical functions of xenobiotic receptors in lipid and glucose metabolism
Wang, J., Lu, P., & Xie, W. (2022) · Medical Review · doi:10.1515/mr-2022-0032 · Cited by 21
Liu, H., Ju, A., Dong, X., Luo, Z., Tang, J., Ma, B., Fu, Y., & Luo, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03957-3 · Cited by 21
Kuo, Y.-C., Chen, I.-Y., Chang, S. C., Wu, S., Hung, T., Lee, P., Shimotohno, K., & Chang, M. (2013) · Liver International · doi:10.1111/liv.12389 · Cited by 20
Li, S., Chen, X., Yu, L., Saltiel, A. R., & Lin, J. D. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1227 · Cited by 23
Diabetes: Symptoms, Cause and Potential Natural Therapeutic Methods
Awasthi, A., Parween, N., Singh, V. K., Anwar, A., Prasad, B., & Kumar, J. (2016) · Advances in Diabetes and Metabolism · doi:10.13189/adm.2016.040102 · Cited by 22
“[17, 18].”
Long-term Effect of Biomineralized Insulin Nanoparticles on Type 2 Diabetes Treatment
Xiao, Y., Wang, X., Wang, B., Liu, X., Xu, X., & Tang, R. (2017) · Theranostics · doi:10.7150/thno.21450 · Cited by 19
“The liver is an organ targeted by insulin [35]; therefore, we used the liver cell line in our in vitro assessments.”
MethodPGC-1αin hepatic UPR during high-fat high-fructose diet and exercise training in mice
Kristensen, C. M., Dethlefsen, M. M., Tøndering, A. S., Lassen, S. B., Nøhr-Meldgaard, J., Ringholm, S., & Pilegaard, H. (2018) · Physiological Reports · doi:10.14814/phy2.13819 · Cited by 22
“The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1a) is known to regulate energy metabolism in several tissues, including the liver (Herzig et al. 2001; Yoon et al. 2001; Puigserver et al. 2003).”
BackgroundFOXO genes in channel catfish and their response after bacterial infection
Gao, L., Yuan, Z., Zhou, T., Yang, Y., Gao, D., Dunham, R. A., & Liu, Z. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.03.010 · Cited by 20
Lack of collagen XVIII leads to lipodystrophy and perturbs hepatic glucose and lipid homeostasis
Petäistö, T., Vicente, D., Mäkelä, K. A., Finnilä, M., Miinalainen, I., Koivunen, J. T., Izzi, V., Aikio, M., Karppinen, S., Devarajan, R., et al. (2020) · The Journal of Physiology · doi:10.1113/jp279559 · Cited by 20
“Peroxisome proliferator-activated receptor γ coactivator 1 α (PGC1α) regulates hepatic glucose production through activation of the entire gluconeogenic pathway (Yoon et al. 2001; Puigserver et al. 2003; Lin et al. 2004; Rodgers et al. 2005).”
BackgroundVechetti, I. J., Bertaglia, R. S., Fernández, G. J., de Paula, T. G., de Souza, R. W. A., de Moraes, L. N., Mareco, E. A., de Freitas, C. E. A., Aguiar, A. F., Carvalho, R. F., et al. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv064 · Cited by 23
Gene program-specific regulation of PGC-1α activity
Schmidt, S. F., & Mandrup, S. (2011) · Genes & Development · doi:10.1101/gad.2076411 · Cited by 24
“2005), and gluconeogenesis in liver (Yoon et al. 2001; Puigserver et al. 2003; Rhee et al. 2003).”
BackgroundQuagliarini, F., Makris, K., Friano, M. E., & Uhlenhaut, N. H. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad048 · Cited by 22
PGC-1α in aging and lifelong exercise training-mediated regulation of UPR in mouse liver
Kristensen, C. M., Brandt, C. T., Ringholm, S., & Pilegaard, H. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.08.006 · Cited by 19
“PGC-1α is known to regulate energy metabolism in several tissues including the liver (Herzig et al., 2001; Puigserver et al., 2003; Yoon et al., 2001).”
BackgroundPan, H., Hu, Z., Shao, Z., & Ning, Y. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2035764 · Cited by 20
He, Q., Gao, L., Zhang, F., Yao, W., Wu, J., Song, N., Luo, J., & Zhang, Y. (2023) · Journal of Animal Science · doi:10.1093/jas/skad286 · Cited by 18
“FoxO1 acts as an important mediator of insulin, and its transcriptional activity is reduced upon insulin-mediated phosphorylation (Puigserver et al., 2003).”
BackgroundDoes chasing selected ‘Fox’ to the nucleus prevent diabetes?
Wang, H., & Wollheim, C. B. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.04.003 · Cited by 18
Li, L., Naples, M., Song, H., Yuan, R., Ye, F., Shafi, S., Adeli, K., & Ng, D. S. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00278.2007 · Cited by 18
“, PEPCK and glucose 6-phosphate and activating the process of glucose production (22).”
BackgroundAnti-angiogenic activity of water extract from Euphorbia pekinensis Rupr
Zhang, W., Liu, B., Feng, Y., Liu, J., Ma, Z., Zheng, J., Xia, Q., Ni, Y., Li, F., & Lin, R. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.05.033 · Cited by 18
PAS Kinase deficiency alters the glucokinase function and hepatic metabolism
Pérez-García, A., Dongil, P., Hurtado-Carneiro, V., Blázquez, E., Sanz, C., & Álvarez, E. (2018) · Scientific Reports · doi:10.1038/s41598-018-29234-8 · Cited by 21
PGC-1α activation: a therapeutic target for type 2 diabetes?
Yuan, D., Xiao, D., Gao, Q., & Zeng, L. (2018) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-018-0622-y · Cited by 20
Paudel, P., Seong, S. H., Jung, H. A., & Choi, J. S. (2019) · ACS Omega · doi:10.1021/acsomega.9b01433 · Cited by 20
A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control
Ma, Y., Liu, S., Jun, H., Wang, J., Fan, X., Li, G., Yin, L., Rui, L., Weinman, S. A., Gong, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001061r · Cited by 20
She, Y., Sun, J., Hou, P., Fang, P., & Zhang, Z. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113313 · Cited by 18
Huang, X., He, Q., Zhu, H., Fang, Z., Che, L., Lin, Y., Xu, S., Zhuo, Y., Hua, L., Wang, J., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.07.010 · Cited by 19
Kanno, J., Aisaki, K., Igarashi, K., Kitajima, S., Matsuda, N., Morita, K., Tsuji, M., Moriyama, N., Furukawa, Y., Otsuka, M., et al. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.643 · Cited by 18
miR-696 plays a role in hepatic gluconeogenesis in ob/ob mice by targeting PGC-1α
Fang, Z., Li, P., Jia, W., Jiang, T., Wang, Z., & Xiang, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2659 · Cited by 19
“These downstream effects further support the hypothesis that miR-696 negatively regulates PGC-1 α protein expression in the mouse liver and then coordinates the expression of characteristic hepatic gluconeogenic enzymes, including PEPCK through coactivating transcription factors, such as HNF-4 α , FOXO1, and therefore…”
InfluentialDiscovering orphans' sweet secret: NR4A receptors and hepatic glucose production
Díaz, M. B., Lemke, U., & Herzig, S. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.005 · Cited by 19
“Apart from hyperglycemia, a subacute inflammation represents an additional characteristic feature of insulin-resistant type II diabetes, driven at least in part by the proinflammatory response of macrophages (Saltiel, 2001).”
BackgroundMore TORC for the gluconeogenic engine
Cheng, A., & Saltiel, A. R. (2006) · BioEssays · doi:10.1002/bies.20375 · Cited by 19
The tangled path to glucose production
Matsumoto, M., & Accili, D. (2006) · Nature Medicine · doi:10.1038/nm0106-33 · Cited by 18
Self-citationImpaired endothelial function contributes to cardiac dysfunction: role of mitochondrial dynamics
Gutierrez‐Huerta, C. A., Quiroz-Delfi, G., Faleel, F. D. M., & Beyer, A. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00531.2024 · Cited by 19
Wang, J., Rappold, G., & Fröhlich, H. (2022) · Genes · doi:10.3390/genes13010127 · Cited by 17
“The mRNA levels of Foxp1, Foxo1, Pgc-1α, and Tfam were analyzed in WT and Foxp1+/− tissue by quantitative real-time PCR at P1.”
BackgroundInfluentialYang, X., Wang, C., Zheng, Q., Liu, Q., Wawryk, N. J. P., & Li, X. (2022) · ACS Omega · doi:10.1021/acsomega.2c06296 · Cited by 17
SLC7A14 imports GABA to lysosomes and impairs hepatic insulin sensitivity via inhibiting mTORC2
Jiang, X., Liu, K., Jiang, H., Yin, H., Wang, E., Cheng, H. B., Yuan, F., Xiao, F., Wang, F., Lu, W., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2022.111984 · Cited by 22
Mal, S., Majumder, D., Birari, P., Sharma, A. K., Gupta, U. D., Jana, K., Kundu, M., & Basu, J. (2024) · FEBS Letters · doi:10.1002/1873-3468.15001 · Cited by 18
“PGC-1 α is required for the expression of gluconeogenic enzymes such as glucose-6-phosphatase ( G6p ) and phosphoenolpyr-uvate carboxykinase ( Pepck ) [82,83].”
Critical physiological and pathological functions of Forkhead Box O tumor suppressors
Dumitrascu, G. R., & Bucur, O. (2013) · Discoveries · doi:10.15190/d.2013.5 · Cited by 19
“FOXO proteins are involved in critical physiological processes that regulate cellular metabolic activity in many organs, such as liver, pancreas, adipose tissue and hypothalamus 73, 74, 75, 76 .”
BackgroundFunction of phosphoenolpyruvate carboxykinase in mammary gland epithelial cells
Hsieh, C., Huang, C. Y., Bederman, I. R., Yang, J., Beidelschies, M. A., Hatzoglou, M., Puchowicz, M., & Croniger, C. M. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m012666 · Cited by 17
Insulin inhibits hepatocyte iNOS expression induced by cytokines by an Akt-dependent mechanism
Harbrecht, B. G., Nweze, I. C., Smith, J. W., & Zhang, B. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00114.2011 · Cited by 18
High-fat diet alters PAS kinase regulation by fasting and feeding in liver
Pérez-García, A., Dongil, P., Hurtado-Carneiro, V., Blázquez, E., Sanz, C., & Álvarez, E. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.003 · Cited by 20
Choi, W., Yoon, J.-H., Song, J.-Y., Jeon, B., Park, J.-M., Koh, D., Ahn, Y., Kim, K., Lee, I. K., & Hur, M. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.04.001 · Cited by 17
Self-citationXiong, Q., Wu, Y., Yang, M., Wu, G., Wang, Y., Wang, H., Feng, J., Song, L., Tong, B., He, G., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109503 · Cited by 18
Aggarwal, H., Pathak, P., Singh, P., Gayen, J. R., Jagavelu, K., & Dikshit, M. (2020) · Antioxidants · doi:10.3390/antiox9080736 · Cited by 20
“PGC-1α induction promotes mitochondrial biogenesis as well as augmented gluconeogenic gene expression and increased lipid oxidation in altered metabolic states [62].”
BackgroundNakamura, M., Satoh, N., Horita, S., & Nangaku, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015204 · Cited by 20
“For example, FOXO1 activates gluconeogenic genes in the liver (Puigserver et al., 2003), negatively regulates SREBP1c (Kamei et al.”
BackgroundYu, S., Wang, W., Wang, H., Bu, T., Liu, L., Zhao, R., Li, S., Liu, D., & Wu, J. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200681 · Cited by 18
dos Santos, G. A., de Moura, R. F., Vitorino, D. C., Roman, E. A. F. R., Torsoni, A. S., Velloso, L. A., & Torsoni, M. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.018 · Cited by 17
“These proteins are all related to control of genes involved in gluconeogenesis (Chanda et al., 2011; Inoue et al., 2004; Koo et al., 2005; Puigserver et al., 2003).”
Chang, J. S., Jun, H., & Park, M. (2016) · Physiological Reports · doi:10.14814/phy2.13013 · Cited by 19
“PGC-1a is involved in fasting-induced fatty acid oxidation in the liver (Yoon et al. 2001; Puigserver et al. 2003; Rhee et al. 2003).”
BackgroundMu, S., Liu, J., Guo, W., Zhang, S., Xiao, X., Wang, Z., & Zhang, J. (2017) · Obesity Facts · doi:10.1159/000470912 · Cited by 18
Cui, C., Meng, Z., Zheng, Y., Hu, B. Q., & Shen, E. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5375 · Cited by 19
XBP-1s Is Linked to Suppressed Gluconeogenesis in the Ebb Phase of Burn Injury
Brooks, N. C., Marshall, A. H., Qa’aty, N., Hiyama, Y., Boehning, D. F., & Jeschke, M. G. (2013) · Molecular Medicine · doi:10.2119/molmed.2012.00348 · Cited by 17
p53 and metabolism: Old player in a new game
Sen, N., Satija, Y. K., & Das, S. (2012) · Transcription · doi:10.4161/trns.20094 · Cited by 17
Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans
Bertinat, R. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000285 · Cited by 20
“Also, despite NaW did not affect expression of the transcription factors hepatic nuclear factor 4 alpha (HNF4α) and Forkhead box protein O1 (FOXO1), both important contributors in regulation of hepatic gluconeogenesis, it did reduce expression of Peroxisome Proliferator-Activated Receptor (PPAR)-γ coactivator 1 alpha…”
Background
Metadata
- Authors
- Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2003-05-18
- Volume
- 423
- Issue
- 6939
- Pages
- 550-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1583767403
- Cited by
- 1,487
- References
- 22
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 46 · 2023: 53 · 2022: 62 · 2021: 67 · 2020: 71 · 2019: 61 · 2018: 86 · 2017: 76 · 2016: 59 · 2015: 75 · 2014: 71 · 2013: 68 · 2012: 81
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Taiho Pharmaceutical
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- hepatic gluconeogenesis, insulin signaling, FOXO1, PGC-1α, transcriptional coactivation, Akt phosphorylation, fasting, diabetes mellitus, glucocorticoids, glucagon, gluconeogenic gene expression, hepatocytes, forkhead transcription factor
- MeSH terms
- Forkhead Box Protein O1, Animals, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Gluconeogenesis, Insulin, Liver, Precipitin Tests, Protein Binding, RNA, Messenger, Transcription Factors, Hepatocytes, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.